On June 19th, the three-day CPHI (World Pharmaceutical Raw Materials China Exhibition) opened in Shanghai, China. A.H.A International and Huayi Pharmaceutical jointly participated in the exhibition, showcasing W2P02.
The Chinese pharmaceutical industry plays an important role in the global pharmaceutical industry value chain. As a leading international trade enterprise in the pharmaceutical industry, A.H.A International and Huayi Pharmaceutical have attracted numerous domestic and foreign customers and partners to come to the exhibition booth for negotiation with their dual wing development model of characteristic international trade and high-end pharmaceutical research and manufacturing.
This exhibition was led by Liang Qing, Chairman of A.H.A International Co., Ltd, and a team led by Gao Yu, Chairman of Huayi Pharmaceutical, Yu Lingmin, Vice President of A.H.A International, Jiang Yelong, Vice President and General Manager of Food Ingredients Division, Wang Yunfeng, Vice President, Wang Qizhuang, Assistant President and General Manager of Pharmaceutical Division, and Li Yuanyuan, General Manager of Nutrition and Health Division, participated in discussions on products and services that interested customers.
The field of big health is one of the characteristic international trade businesses of A.H.A International Co., Ltd. After years of exploration and deep cultivation, an industrial chain development model mainly consisting of pharmaceutical products, nutrition products, and food ingredients has gradually formed, among which pharmaceutical products are an important component in the field of big health. A.H.A International Co., Ltd hopes to discuss the future development of pharmaceutical trade with CDMO business partners, manufacturers, and distributors from both domestic and international sources, promote the transformation of the medical model pharmaceutical trade, and build a reputation for integrated pharmaceutical trade services.
A.H.A International Co., Ltd has over 40 years of professional foreign trade experience and resources has multiple franchise qualifications, and has passed multiple international certifications such as AEO, ISO, Ecovadis, etc. Relying on a professional business team, we aim to create one-stop foreign trade solutions such as “marketing, regulatory support, business operations, logistics support, and after-sales service”. Through the continuous accumulation of professional resources and experience in research and development, production, and registration, we continuously explore providing professional and reliable integrated pharmaceutical CDMO operation solutions for domestic and foreign manufacturers, distributors, and partners. The company’s trade scope covers nearly 100 countries and regions, with nearly 1000 cooperative suppliers, operating nearly 1000 types of goods, and an average annual export of over 4000 standard containers. Establish overseas operating companies in key trade areas to provide customers with warehousing and localization services.